Skip to content
healthcare.dev
Get a free key

Ibuprofen and Diphenhydramine Citrate

NDC 55111-565, Ibuprofen and Diphenhydramine Citrate, tablet, from Dr. Reddy's Laboratories Limited.

Product NDC
55111-565
Status
Listed
Labeler
Dr. Reddy's Laboratories Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090619
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55111-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IBUPROFEN200 mg/1
  • DIPHENHYDRAMINE CITRATE38 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
55111-565-05551110565051 BOTTLE in 1 CARTON (55111-565-05) / 500 TABLET in 1 BOTTLE
55111-565-14551110565141 BOTTLE in 1 CARTON (55111-565-14) / 20 TABLET in 1 BOTTLE
55111-565-18551110565181 BOTTLE in 1 CARTON (55111-565-18) / 180 TABLET in 1 BOTTLE
55111-565-30551110565301 BOTTLE in 1 CARTON (55111-565-30) / 30 TABLET in 1 BOTTLE
55111-565-40551110565401 BOTTLE in 1 CARTON (55111-565-40) / 40 TABLET in 1 BOTTLE
55111-565-80551110565801 BOTTLE in 1 CARTON (55111-565-80) / 80 TABLET in 1 BOTTLE
55111-565-90551110565901 BOTTLE in 1 CARTON (55111-565-90) / 90 TABLET in 1 BOTTLE
55111-565-92551110565922500 TABLET in 1 POUCH (55111-565-92)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55111-565 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55111-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55111-565. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.